| Mrs Marianna V Sieracki, PA-C | |
|
430 E Division St, Fond Du Lac, WI 54935-4560 | |
| (920) 929-2300 | |
| Not Available |
| Full Name | Mrs Marianna V Sieracki |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Location | 430 E Division St, Fond Du Lac, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659786374 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 3334 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Marianna V Sieracki, PA-C 420 E Division St, Fond Du Lac, WI 54935-4560 Ph: (920) 926-8340 | Mrs Marianna V Sieracki, PA-C 430 E Division St, Fond Du Lac, WI 54935-4560 Ph: (920) 929-2300 |
News Archive
Clinicians caring for vulnerable babies in the neonatal intensive care unit need to closely monitor their vital signs, but precisely gauging the function of their tiny hearts has remained elusive.
DMI, a leading IT solutions and business strategy consulting firm, today announced that it has been awarded a multi-million dollar contract to modernize and maintain the suite of enterprise applications used by the Department of Health and Human Services (HHS) Office of Inspector General (OIG). This is DMI's fourth prime contract with HHS in the last 18 months.
Caris Life Sciences, a leading biotechnology company focused on fulfilling the promise of precision medicine, today announced the results of a study identifying the clinical benefit of targeted therapy in colorectal cancer (CRC) with high microsatellite instability (MSI-H), a predisposition that occurs in 15% of all CRCs causing significantly different prognosis and response to treatment.
Allos Therapeutics, Inc. today announced topline results from the Company's randomized Phase 2b investigational trial of FOLOTYN® (pralatrexate injection) versus erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC) who had received one or two prior systemic treatments including at least one prior platinum-based regimen. The objective of the trial was to estimate the efficacy of FOLOTYN compared to that of erlotinib as assessed by overall survival.
› Verified 1 days ago
Mr. Joseph Jon Deboer, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 920-929-2300 | |
Mrs. Adriane Janet Leonard, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 920-929-2300 Fax: 920-926-8370 | |
Tristan Pitt, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 920-929-2300 | |
Erin C. Rottier, M.S., PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 920-929-2300 | |
Teegan R Kraus, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 889 E Johnson St, Fond Du Lac, WI 54935 Phone: 920-367-6700 Fax: 262-700-4657 | |
Mrs. Cynthia Nicole Wittwer, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 920-929-2300 | |
Betty Xiong-thompson, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 210 Wisconsin American Dr, Fond Du Lac, WI 54937 Phone: 920-907-7000 Fax: 920-907-7162 |